Prostaglandin E2 tablets prevent aspirin-induced blood loss in man

Digestive Diseases and Sciences
K Y YikW C Watson

Abstract

A double-blind study was performed to determine the effect of prostaglandin E2 (PGE2) tablets on aspirin-induced blood loss in 20 healthy male volunteers. All subjects took aspirin, and 9 in the control group and 11 in the treatment group received placebo and PGE2 respectively. One tablet of PGE2, 0.5 mg, was given four times daily for five days. Two tablets of unbuffered aspirin (640 mg) were given four times daily for four days commencing one day after the start of the PGE2 or placebo. Fecal blood loss was measured using 51Cr-labeled red cells. There was no significant difference in serum salicylate levels. There was a significant increase in fecal blood loss in control subjects on the third and fourth days on aspirin and for 4 days following aspirin ingestion. In the treatment group, fecal blood loss was prevented by PGE2.

References

Feb 10, 1979·Lancet·C JohanssonS Bergström
Jan 1, 1979·Gut·T A Miller, E D Jacobson
Apr 1, 1978·The American Journal of Digestive Diseases·J P BoltonM M Cohen
Nov 1, 1973·British Journal of Pharmacology·I H Main, B J Whittle
Apr 1, 1974·The Journal of Obstetrics and Gynaecology of the British Commonwealth·M ThieryJ J Amy
Apr 30, 1971·Annals of the New York Academy of Sciences·S Karim
Jan 1, 1972·The Journal of Obstetrics and Gynaecology of the British Commonwealth·S M Karim, G M Filshie
Jan 21, 1967·British Medical Journal·D N Croft, P H Wood
Dec 14, 1968·British Medical Journal·K Goulston, A R Cooke
Mar 1, 1970·The Journal of Obstetrics and Gynaecology of the British Commonwealth·S M KarimR C Patel
Jan 30, 1971·British Medical Journal·S M Karim, S D Sharma
Apr 1, 1971·The Journal of Obstetrics and Gynaecology of the British Commonwealth·S M Karim

❮ Previous
Next ❯

Citations

Apr 2, 1999·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M A KhanD P Mikhailidis
Jan 1, 1987·Scandinavian Journal of Gastroenterology. Supplement·A Aly
Mar 15, 2001·Drug Development and Industrial Pharmacy·A K BansalA K Sharma
Jan 1, 1987·British Journal of Urology·J Y JeremyP Dandona
Nov 1, 1985·Journal of Clinical Pharmacology·N CharletR J Wills
Dec 1, 1989·Alimentary Pharmacology & Therapeutics·K BerstadA Berstad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.